Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.550
-0.010 (-0.64%)
Nov 21, 2024, 1:19 PM EST - Market open

Cardiol Therapeutics Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-36.14-28.13-30.93-31.64-20.64-13.68
Upgrade
Depreciation & Amortization
0.390.250.220.220.230.15
Upgrade
Asset Writedown & Restructuring Costs
--1.360.080.080.5
Upgrade
Stock-Based Compensation
12.144.175.5412.612.813.27
Upgrade
Other Operating Activities
-1.95-0.93-9.15-4.890.070.01
Upgrade
Change in Accounts Receivable
0.120.07-0.14-0.060.010.02
Upgrade
Change in Inventory
---0.025.850.14
Upgrade
Change in Accounts Payable
-0.9-1.294.472.391.83-1.5
Upgrade
Change in Other Net Operating Assets
0.390.681.42-2.270.64-0.28
Upgrade
Operating Cash Flow
-25.93-25.18-27.22-23.54-9.13-11.38
Upgrade
Capital Expenditures
-0.03-0.06-0.07-0.01-0.04-0.42
Upgrade
Investing Cash Flow
-0.03-0.06-0.07-0.01-0.04-0.42
Upgrade
Long-Term Debt Repaid
--0.06-0.05-0.05-0.05-0.02
Upgrade
Net Debt Issued (Repaid)
-0.04-0.06-0.05-0.05-0.05-0.02
Upgrade
Issuance of Common Stock
0.18--98.7217.432.05
Upgrade
Other Financing Activities
----5.23-1.09-
Upgrade
Financing Cash Flow
0.14-0.06-0.0593.4416.32.03
Upgrade
Foreign Exchange Rate Adjustments
1.170.762.92-0.01-0.06-
Upgrade
Net Cash Flow
-24.66-24.54-24.4369.877.07-9.78
Upgrade
Free Cash Flow
-25.96-25.24-27.3-23.55-9.17-11.8
Upgrade
Free Cash Flow Margin
----29904.22%--
Upgrade
Free Cash Flow Per Share
-0.38-0.39-0.44-0.54-0.31-0.46
Upgrade
Levered Free Cash Flow
-19.97-14.99-20.64-4.61-1.61-6.06
Upgrade
Unlevered Free Cash Flow
-19.97-14.99-20.64-4.61-1.61-6.06
Upgrade
Change in Net Working Capital
0.570.730.49-6.74-8.321.62
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.